Characteristics, outcomes of US children, adolescents with multisystem inflammatory syndrome in children compared with severe COVID-19


What The Study Did:
National COVID-19 registry data are used in this study to describe the epidemiology, clinical characteristics, complications, and hospital and postdischarge outcomes of pediatric patients with multisystem inflammatory syndrome in children (MIS-C) and to compare each in patients with severe COVID-19.

Adrienne G. Randolph, M.D., of Boston Children’s Hospital, is the corresponding author.

To access the embargoed study:
Visit our For The Media website at this link


Editor’s Note: The article includes conflict of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.


Media advisory:
The full studyis linked to this news release.

Embed this link to provide your readers free access to the full-text article 
This link will be live at the embargo time

Media Contact
JAMA Network Media Relations
[email protected]

Leave A Reply

Your email address will not be published.